+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Topirimate Test"

2021 Topirimate Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2021 Topirimate Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2021
  • Japan, United States, ... Japan, United States, Europe
From
2020 Topirimate Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Topirimate Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Topirimate Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of topiramate, an anticonvulsant drug used to treat epilepsy and migraine headaches. The test is used to measure the concentration of topiramate in a patient's blood or urine sample. It is used to monitor the effectiveness of the drug and to ensure that the patient is taking the correct dosage. The test is also used to detect the presence of topiramate in cases of drug abuse or overdose. The Topirimate Test market is a niche segment of the IVD market, with a focus on providing accurate and reliable results. The market is highly competitive, with a number of companies offering a range of products and services. Companies in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Bio-Rad Laboratories. Show Less Read more